Wheat ergot fungus-derived and modified drug for inhibition of intracranial aneurysm rupture due to dysfunction of TLR-4 receptor in Alzheimer's disease.
Sandip DebnathDevesh SharmaSomdatta Yashwant ChaudhariRitika SharmaAmir Afzal ShaikhRahul Subhash BuchadeKavindra Kumar KesariAbdel-Fattah M Abdel-FattahMohammad AlgahtaniMayyadah MheidatRawidh AlsaidalaniTapas PaulAmany A SayedMohamed M Abdel-DaimPublished in: PloS one (2023)
As a result of this, the results of our research may be relevant for future research into the efficacy of 2-bromoergocryptine mesylate as a potential lead treatment for TLR4 receptors in intracranial aneurysm rupture in AD.